Monday, June 14, 2021

Novavax claims effectiveness is 90% and will apply to the FDA for authorization

Research, editing : Gan Yung Chyan, KUCINTA SETIA



Like MVC-COV1901 and UBI covi vaccine, the United States Novavax vaccine is a subunit protein vaccine. According to multiple media reports in the United States, the company announced on Monday that the third phase of clinical trials in the United States and Mexico confirmed the safety and overall efficacy of 90.4%, and found that after two injections, Novavax can prevent 100% of the infected people from deteriorating to moderate to severe illness. Novavax plans to apply for authorization from the US Food and Drug Administration in the third quarter of 2021.


at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

$14 billion arms sale to Taiwan suspended? U.S. to send 5,000 more troops to Poland

Translation, editing : Gan Yung Chyan, KUCINTA SETIA 50 Updates on U.S., Taiwan, Poland, Iran War News (1) Trump said he would speak with La...